BETNESOL

This brand name is authorized in Canada, France, Ireland, Israel, Netherlands, UK.

Active ingredients

The drug BETNESOL contains one active pharmaceutical ingredient (API):

1	Betamethasone phosphate disodium UNII 7BK02SCL3W - BETAMETHASONE SODIUM PHOSPHATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BETNESOL Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07EA04	Betamethasone	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EA Corticosteroids acting locally
Discover more medicines within A07EA04
H02AB01	Betamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02060884
FR	Base de données publique des médicaments	60152607, 62421127, 66322048
GB	Medicines & Healthcare Products Regulatory Agency	31481
IE	Health Products Regulatory Authority	14842, 15113
IL	מִשְׂרַד הַבְּרִיאוּת	6015
NL	Z-Index G-Standaard	14655411
NL	Z-Index G-Standaard, PRK	1317